Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. The page content and study details remain unchanged.SummaryDifference0.0%

- Check27 days agoChange DetectedThe funding-lapse notice about information timeliness has been removed. Previously, the page included a statement that information may not be up to date due to lapses in government funding, and that NIH operations status could be found at opm.gov.SummaryDifference0.3%

- Check42 days agoChange DetectedOnly minor visual and layout adjustments are evident. There are no changes to core study information such as the title, conditions, eligibility criteria, enrollment, or outcomes.SummaryDifference0.3%

- Check71 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top element.SummaryDifference0.2%

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.